The Quantitative Decision-making Special Interest Group (QDM SIG) was formed in October 2017. It is a group of statisticians from industry and academia, with experience and interests in statistical methods for quantitative decision-making in drug development. The objectives of the SIG are:
| Gianluca Baio (UCL) |
| Nicolas Bonnet (Sanofi) |
| Sarah Bray (Amgen) |
| Alex Carlton (GSK) |
| Jacquie Christie (GSK) |
| Pierre Colin (Debiopharm) |
| Paul Frewer (AstraZeneca) |
| Heiko Goette (Merck) |
| Martin Johnson (UCB Pharma) |
| Kevin Kunzmann (Cambridge University) |
| John-Philip Lawo (CSL Behring) |
| Jesper Madsen (Novo Nordisk) |
| Pavel Mozgunov (Lancaster University) |
| Emmanuel Pham (Ipsen) |
| Veronique Robert (Servier) |
| Oliver Sailer (Boehringer Ingelheim ) |
| Gaëlle Saint-Hilary (Servier) (Chair) |
| Guido Thömmes (Grunenthal) |
For further information, or to join the QDM SIG, please contact the chair:
Gaelle Saint-Hilary (Servier and Politecnico di Torino)
gsainthilary@gmail.com
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
This presentation will give some background regarding the ‘Carcinogenicity Statistics Discussion Group’. The talk will review the history of the group, outline the current status, and give an overview of the types of topics discussed.
This year's Annual General Meeting will focus on how PSI has navigated the challenges of the past year and adapted to the new online world, as well as how we plan to embrace a new Board structure and new opportunities as we move forward.
Our next journal club features two papers on the topic of “The Use of External Controls in Clinical Trials”. Please join us to hear Chris Harbron (Roche) and Margaret Gamalo (Pfizer) present their recent work. The webinar will be chaired by Nigel Stallard (Warwick University).
We’re now searching at all levels for Biostatisticians and Statistical Programmers to join our International BARDS Health Technology Assessment team at our London and Zurich hubs.
The Associate Director of Biostatistics is the key client interface for all statistical issues and discussions.
In this role you will consult in the design of complex and innovative studies and clinical trial programs as well as Leading DMC/DSMB processes.
Join our growing team and discover your extraordinary potential by working as a Covance by Labcorp Biostatistician 2 within our early phase biostatistics department.
This is an excellent opportunity for someone that loves working directly with clients, contributing as a high-level project lead and key contributor.
Join our growing team and discover your extraordinary potential by working as a Covance by Labcorp Principal Biostatistician.
As a seasoned Biostatistician, will work primarily on Immunology: GI and Dermatology trials with a focus on Late Phase studies. Some PK Analysis experience highly desired.
As a seasoned Biostatistician, will work primarily in late phase oncology.
As an experienced pharmaceutical statistician, you will support Cytel and a client of our Functional Service Provider (FSP) division.
As a Sr Bios, you will function independently as Lead Statistician on projects and support/project statistician on others.
As a Sr Mgr, Biostatistics you will manage a team of Statisticians and Programmers within the FSP department, as well as managing project work.
At its core, the role of a Senior Statistician at Veramed is to provide statistical support to the statistics and programming department across a range of projects, clients and therapeutic areas.
As a Senior or Principal Biotatistician, you will hold a combined project leadership and hands-on technical statistics role, working across a range of phases and therapeutic areas.
You will participate in the development of study protocols including participation in study design discussions and sample size calculations, and review CRFs and data review guidelines.
As a Senior or Principal Statistician, you will hold a combined project leadership and hands-on technical statistics role., working across a range of phases and therapeutic areas.
We are looking for passionate and motivated statisticians to work within our Services team to deliver high quality, innovative, analytical services within a clinical setting as our KerusCloud platform moves into the next phase.
Would you like to join a dynamic, growing firm where you can really make an impact, not just on the company but to accelerate drug development and ultimately benefit patients?
Have you experience in the application of statistics in the pharmaceutical, healthcare or life science sectors? Do you want to be at the forefront of statistical innovations, leading the way on clinical trial design and analysis?
As a Statistics Manager, you will hold a combined line management, project leadership and technical statistical role, working across a range of phases and therapeutic areas.
